Company intelligence / Profile preview

Rosa-Phytopharma

Paris, France

Ownership: Private
Development stage: Other

Overview

Rosa-Phytopharma is a long-established French pharmaceutical laboratory specializing in the development and commercialization of over-the-counter (OTC) medicines and healthcare products. The company is best known for its flagship product, Gelopectose, a thickener used to manage gastroesophageal reflux in infants. Beyond pediatric care, Rosa-Phytopharma maintains a portfolio of traditional treatments for common ailments such as coughs, sore throats, and digestive issues. The company operates primarily within the French market, distributing its products through pharmacies and healthcare providers. It maintains a focus on reliable, time-tested formulations that address everyday health needs.

Therapeutic areas: Infectious DiseasesPulmonologyGastroenterology
Modalities: Small moleculeNatural product
Industry: Biotech

Beyond the preview

Go deeper on Rosa-Phytopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rosa-Phytopharma.

Explore the full profile